Gab2 can recruit Shp2 to activate Ras/ERK signaling in breast cancer and melanoma (43, 44), and the PI3K/Akt signaling pathway has been reported to be modulated by Gab2 in breast cancer (45), ovarian cancer (30, 37), and melanoma (46). This evidence concerns the gene AKT1 and breast carcinoma.